InhaleRx Limited

Equities

IRX

AU0000179475

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 08:43:42 17/07/2024 am IST			5-day change	1st Jan Change
0.028 ^AUD	+7.69%		+7.69%	-3.45%

30/05	InhalerX Files Investigational New Drug Application with US FDA for Drug-Device Pain Medication	MT
28/03	InhaleRx Limited announced that it expects to receive AUD 0.5 million in funding from Peak Asset Management, LLC	CI

Lifespot Health Ltd. has completed an IPO in the amount of AUD 8 million.

January 10, 2017 at 10:30 am IST

Lifespot Health Ltd. has completed an IPO in the amount of AUD 8 million. Security Name: Shares Security Type: Common Stock Securities Offered: 40,000,000 PriceRange: AUD 0.2 Transaction Features: Carve-out

Latest news about InhaleRx Limited

InhalerX Files Investigational New Drug Application with US FDA for Drug-Device Pain Medication	30/05	MT
InhaleRx Limited announced that it expects to receive AUD 0.5 million in funding from Peak Asset Management, LLC	28/03	CI
InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2023	14/02	CI
InhaleRx to Focus on Breakthrough Cancer Pain for Phase 2 Trial of Cannabinoid Analgesic	10/01	MT
InhaleRx Secures Nearly AU$550,000 R&D tax Incentive Prepayment	21/12	MT
InhaleRX Completes Phase One Trial for Pain Medication Device	04/12	MT
InhaleRx Files Ethics Application for Panic Disorder Trial	18/23/18	MT
InhaleRx Limited Reports Earnings Results for the Half Year Ended June 30, 2023	22/23/22	CI
InhaleRx Limited Announces Change of Registered Office Address	03/23/03	CI
InhaleRx Limited Announces Executive Changes	03/23/03	CI
InhaleRx Completes First Cohort of Phase One Clinical Trial	14/23/14	MT
Australian Shares Retreat Anew on Rate Hike, Slower-than-Expected GDP Growth	07/23/07	MT
InhaleRx Doses First Individuals for Phase One Trial of Inhalable Pain Medication	07/23/07	MT
InhaleRx Limited Auditor Raises 'Going Concern' Doubt	30/23/30	CI
InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27	CI
InhaleRx Hires Contract Research Organization for Upcoming Clinical Trials	22/22/22	MT
Inhalerx Limited Announces Fda Pre-Ind Application Update	12/22/12	CI
InhaleRx Limited Announces Board and Management Changes	27/22/27	CI
InhaleRx Limited Announces the Appointment of Darryl Davies as Chief Executive Officer	27/22/27	CI
InhaleRx Raises $810,000 From Share Placement	19/22/19	MT
InhaleRx Limited Reports Earnings Results for the Half Year Ended June 30, 2022	31/22/31	CI
InhaleRx Limited Auditor Raises 'Going Concern' Doubt	31/22/31	CI
InhaleRx Secures Licenses to Sell, Supply Controlled Substances	30/22/30	MT
Victorian Department of Health & Human Services Grants Wholesale Licenses to Inhalerx Limited to Sell and Supply Poisons or Controlled Substances	30/22/30	CI
InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2021	28/22/28	CI

Chart InhaleRx Limited

Duration

Period

More charts

Company Profile

Inhalerx Limited is an Australia-based healthcare company. The Company is focused on developing medicinal drug-device products to address unmet medical needs in the pain management and mental health sectors. The Company partners with educators in their technical and therapeutic fields, to provide inhalation therapies that deliver added value for patients, doctors, business partners, governments, and stakeholders alike. Its Medihale Inhaler is a sealed pod inhaler designed specifically for use with inhaled formulations. It utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material. The sealed tamper-proof Medihale Pods provide patients with additional security. The Medihale Protective Charging Case automatically recharges the Medihale Inhaler when the inhaler is returned to its case. The Medihale Protective Charging Case even has a dedicated storage space to carry an extra Medihale c-liquid Pod.

Sector

Advanced Medical Equipment & Technology

Calendar

30/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INHALERX LIMITED	-3.45%	3.58M
THERMO FISHER SCIENTIFIC	+4.57%	212B
DANAHER CORPORATION	+8.61%	186B
INTUITIVE SURGICAL, INC.	+26.34%	151B
BOSTON SCIENTIFIC CORPORATION	+33.90%	114B
SIEMENS HEALTHINEERS AG	+2.89%	65.57B
EDWARDS LIFESCIENCES CORPORATION	+14.50%	52.61B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-3.30%	46.8B
AGILENT TECHNOLOGIES, INC.	-3.98%	38.95B
GE HEALTHCARE TECHNOLOGIES INC.	+6.66%	37.64B

Other Advanced Medical Equipment & Technology